Clinical trials: Cancer Patients and Physical Activity
Cachexia-Anorexia Syndrome
Exercise Intervention for Patients With Cancer Cachexia: Effects of a 12-week Program and One-year Follow-up.
The prevalence of cancer with cachexia is rising sharply. More than 80% of digestive cancer patients are affected by cancer cachexia.
- Trial name
- 2CAPA (NCT06323733)
- Testing
- Exercise Intervention
- Where
- France
- Volunteers
- 31 people
- Sponsor
- Peyrachon Romane
Breast Neoplasm, Exercise
Oncology Treatment Related Ocular Surface Changes
clinical trial The goal of this clinical trial is to learn if drug trastuzumab works to treat HER2 positive mamma carcinomas without causing dry eye related ocular surface changes in adults.
- Trial name
- 23AA01 (NCT07666724)
- Testing
- Trastuzumab (Herceptin)
- Where
- Hungary
- Volunteers
- 35 people
- Sponsor
- Semmelweis University
Soft Tissue Sarcoma
Exercise and Soft Tissue Sarcoma
The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing.
- Trial name
- NCT04921917
- Testing
- neoadjuvant exercise therapy
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Duke University
Breast Neoplasm Female, Quality of Life
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
Combining a fitness tracker technology with real-time patient-reported outcome monitoring associated with interventions through a health care app is a novel strategy to evaluate metastatic breast cancer patients using Palbociclib…
- Trial name
- WEFITTER (NCT05277935)
- Testing
- Use of the WeCancer app combined with the smartwatch.
- Where
- 4 sites in Brazil
- Volunteers
- 68 people
- Sponsor
- Beneficência Portuguesa de São Paulo
Colorectal Cancer, Fatigue
Exercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer
The purpose of this study was to explore the 12-week effectiveness of home exercise intervention for colorectal cancer patients in improving fatigue, sleep, muscle endurance, and quality of life. A.
- Conditions
- Colorectal Cancer, Fatigue, Quality of Life
- Trial name
- NCT05224518
- Testing
- elastic band training
- Where
- Taiwan
- Volunteers
- 106 people
- Sponsor
- National Taiwan University Hospital Hsin-Chu Branch
Breast Cancer Invasive
Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study
The investigators recruited 1542 Breast Cancer (BC) patients and to randomize the participants in two groups: 773 have received standard recommendations for healthy lifestyle without, however, any active support; 700 have…
- Trial name
- DIANA-5 (NCT05019989)
- Testing
- Intervention group on diet and physical activity, Control group: only public recommendation an lifestyle
- Volunteers
- 1,542 people
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
This study evaluates camidanlumab tesirine in participants with relapsed/refractory Non-Hodgkin or Hodgkin lymphoma.
- Trial name
- NCT02432235
- Testing
- Camidanlumab tesirine
- Where
- 12 sites in United States, United Kingdom
- Volunteers
- 133 people
- Sponsor
- ADC Therapeutics S.A.
Risk Reduction, Urological Cancer
STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation for Risk Reduction in Cancer Surgery
Despite knowledge about the effect of preventive measures in lifestyle, smoking,nutrition, alcohol and physical activity (SNAP), there is a lack of systematic assessment of the overall lifestyle of the patient before surgery and…
- Conditions
- Risk Reduction, Urological Cancer, Surgery, Life Style
- Trial name
- STRONG-CS (NCT04088968)
- Testing
- Prehabilitation
- Where
- Denmark
- Volunteers
- 100 people
- Sponsor
- Bispebjerg Hospital
Metastatic Castration Resistant Prostate Cancer
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer
This is a phase 1, first-in-human study to evaluate Safety, Tolerability, PK, PD, Immunogenicity, and Antitumor Activity of LAVA-1207 alone or with low dose interleukin-2 or Pembrolizumab, in patients with therapy refractory…
- Trial name
- NCT05369000
- Testing
- LAVA-1207, LAVA-1207 plus Pembrolizumab
- Where
- 12 sites in United States, Netherlands and 1 more
- Volunteers
- 96 people
- Sponsor
- Lava Therapeutics
Advanced Solid Tumors
A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
This study is a one-arm, open, multicenter phase 1b/2 clinical trial of PE0116combined with PE0105 in patients with Advanced Solid Tumors, aiming at exploring the MTD and RP2D and observing the preliminary efficacy.The trial can…
- Trial name
- NCT06026501
- Testing
- PE0116,PE0105
- Volunteers
- 120 people
- Sponsor
- Shanghai YingLi Pharmaceutical Co. Ltd.
Myasthenia Gravis
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
The purpose of this study is to demonstrate that a 3 months physical exercise programme improves the Quality of Life of patients with generalized Myasthenia Gravis (MG) stabilized since at least 6 months under prednisone and/or…
- Trial name
- MGEX (NCT02066519)
- Testing
- Physical exercise programme using a rowing machine
- Where
- France
- Volunteers
- 45 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL
This study is to evaluate the safety and clinical activity of idelalisib alone and in combination with rituximab in patients with CLL or SLL.
- Trial name
- NCT01203930
- Testing
- Idelalisib, Rituximab
- Where
- 6 sites in United States
- Volunteers
- 105 people
- Sponsor
- Gilead Sciences
Central Nervous System Neoplasm, Hodgkin Lymphoma
Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study
This study attempts to learn more about the activity levels of adolescent and young adult (AYA) cancer patients or survivors at risk for cardiovascular morbidity and frailty by using a smartphone application called Beiwe.
- Conditions
- Central Nervous System Neoplasm, Hodgkin Lymphoma, Malignant Solid Neoplasm, Non-Hodgkin Lymphoma
- Trial name
- NCT05169151
- Testing
- Smartphone Application
- Where
- United States
- Sponsor
- M.D. Anderson Cancer Center
Melanoma
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
This Phase II study is designed to evaluate the anti-tumor activity of three dose groups of SB-485232 (0.01, 0.1, and 1.0 mg/kg/day) administered intravenously as a single agent in subjects with previously untreated metastatic…
- Trial name
- NCT00107718
- Testing
- SB-485232
- Where
- 20 sites in United States, Australia
- Volunteers
- 64 people
- Sponsor
- GlaxoSmithKline
Advanced Malignant Tumor
A Study of QL1706 in Subjects With Advanced Malignant Tumor
This is an open-label, multicenter, Phase 1, ascending dose escalation study of QL1706 in subjects with advanced malignant tumor. The study will be conducted in 2 parts.
- Trial name
- NCT04296994
- Testing
- QL1706
- Where
- China
- Volunteers
- 99 people
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
Advanced Cancer, Advanced Solid Tumor
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
This is a first-in-human (FIH), open-label, multicenter dose escalation and expansion study of BGB-B3227, a humanized immunoglobulin G1 (IgG1) antibody.
- Conditions
- Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer, Metastatic Solid Tumor
- Trial name
- NCT06540066
- Testing
- BGB-B3227, Tislelizumab, Chemotherapy
- Where
- 12 sites in United States, China and 1 more
- Volunteers
- 35 people
- Sponsor
- BeiGene
Ovarian Cancer, Ovarian Carcinoma
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
The purpose of this research is to determine whether a 16-week virtually supervised aerobic and resistance exercise program is feasible in patients receiving first-line chemotherapy after surgery for ovarian or endometrial cancer…
- Conditions
- Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV, Ovarian Cancer Stage III
- Trial name
- NCT04997096
- Testing
- Exercise, Attention Control
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Dana-Farber Cancer Institute
Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors
RATIONALE: Erlotinib may interfere with the growth of tumor cells and slow the growth of the tumor. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
- Trial name
- NCT00033241
- Testing
- erlotinib hydrochloride, gemcitabine hydrochloride
- Where
- 2 sites in United States
- Sponsor
- OSI Pharmaceuticals
Glioblastoma
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
This non-interventional study aims to investigate change over time in cognitive function, sleep quality, and activity in daily life as important determinants of QoL in a large cohort of GBM patients in Germany treated with…
- Trial name
- NCT04717739
- Testing
- TTFields
- Where
- 36 sites in Germany
- Volunteers
- 500 people
- Sponsor
- NovoCure Ltd.
Recurrent Epithelial Ovarian Cancer
Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer
Single -arm, multicenter phase-II trial for catumaxomab and chemotherapy in patients with recurrent ovarian cancer to investigate the feasibility and clinical activity of initial intraperitoneal catumaxomab followed by…
- Trial name
- NCT01815528
- Testing
- Catumaxomab
- Where
- Germany
- Volunteers
- 2 people
- Sponsor
- JSehouli
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.